Comparison of Analgesic Effects of TAP Block and RSB in RALPs

November 7, 2024 updated by: Zeynep Koc, Diskapi Yildirim Beyazit Education and Research Hospital

Comparison of Analgesic Effects of Subcostal Transversus Abdominis Plane Block and Rectus Sheath Block in Robotic-Assisted Laparoscopic Prostatectomies

In this research, we aim to compare the postoperative analgesic efficacy of these two peripheral blocks in patients undergoing RALP who have received preoperative TAP block and RSB block.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

"Robotic-assisted laparoscopic prostatectomy (RALP) is a minimally invasive and superior technique that provides better visualization and maneuverability compared to open and laparoscopic surgical techniques. Previous studies have shown that RALP offers better postoperative oncological and physiological outcomes compared to open and laparoscopic techniques. However, RALP patients still experience pain lasting for several days postoperatively, which requires the use of analgesics such as opioids. This pain is associated with port site incisions, dissection of the prostate and surrounding tissues, bladder spasms, and transurethral catheter irritation. For this purpose, previous studies have utilized central and peripheral methods to reduce postoperative pain. Previous studies have demonstrated the analgesic benefits of TAP block and rectus sheath block in robotic-assisted radical prostatectomies. However, the number of studies in this area is limited. In this research, we aim to compare the postoperative analgesic efficacy of these two peripheral blocks in patients undergoing RALP who have received preoperative TAP block and RSB block.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Ankara
      • Yenimahalle, Ankara, Turkey
        • Zeynep Koç

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients aged 18-79 who underwent robotic radical prostatectomy and have ASA (American Society of Anesthesiologists) physical status score of 1-3.

Description

Inclusion Criteria:

  • Patients aged 18-79 who underwent robotic radical prostatectomy
  • Patients have ASA (American Society of Anesthesiologists) physical status score of 1-3.

Exclusion Criteria:

  • Patients with an allergy to local anesthetic agents
  • a platelet count below 100,000
  • INR value above 2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
TAP Group
TAP block will be performed immediately after the induction of anesthesia, under ultrasond guidence.
TAP block will be performed immediately after the induction of anesthesia, under ultrasond guidence.
RSB Group
RSB block will be performed immediately after the induction of anesthesia, under ultrasond guidence.
Rectus Sheath block will be performed immediately after the induction of anesthesia, under Ultrasond guidence.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
post operatif analgesia consumption
Time Frame: postoperative 24 hous
postoperative iv-PCA tramadole dose for the first 24 hours from iv-PCA devices.
postoperative 24 hous

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
numerical rating scale (NRS) at rest
Time Frame: popstoperative 1. hour
Recording the patient's pain at rest on the Numerical Rating Scale (NRS) by asking the patient
popstoperative 1. hour
numerical rating scale (NRS) at rest
Time Frame: postoperative 6. hour
Recording the patient's pain at rest on the Numerical Rating Scale (NRS) by asking the patient
postoperative 6. hour
numerical rating scale (NRS) at rest
Time Frame: postoperative 16. hour
Recording the patient's pain at rest on the Numerical Rating Scale (NRS) by asking the patient
postoperative 16. hour
numerical rating scale (NRS) at rest
Time Frame: postoperative 24. hour
Recording the patient's pain at rest on the Numerical Rating Scale (NRS) by asking the patient
postoperative 24. hour
NRS during coughing
Time Frame: postoperative1. hour
The NRS for pain during coughing will be recorded by asking the patient
postoperative1. hour
NRS during coughing
Time Frame: postoperative 6. hour
The NRS for pain during coughing will be recorded by asking the patient
postoperative 6. hour
NRS during coughing
Time Frame: postoperative 16. hour
The NRS for pain during coughing will be recorded by asking the patient
postoperative 16. hour
NRS during coughing
Time Frame: postoperative24. hour
The NRS for pain during coughing will be recorded by asking the patient
postoperative24. hour
postoperative nosia and vomiting (PONV)
Time Frame: postoperative 24 hours
Recording the presence or absence of nausea and vomiting in the patient within the first 24 hours postoperatively
postoperative 24 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 20, 2024

Primary Completion (Estimated)

January 20, 2025

Study Completion (Estimated)

January 30, 2025

Study Registration Dates

First Submitted

November 7, 2024

First Submitted That Met QC Criteria

November 7, 2024

First Posted (Estimated)

November 8, 2024

Study Record Updates

Last Update Posted (Estimated)

November 8, 2024

Last Update Submitted That Met QC Criteria

November 7, 2024

Last Verified

November 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Pain

Clinical Trials on TAP Block

Subscribe